Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Anaptysbio (ANAB) Shares Outstanding (Diluted Average): 2019-2024

Historic Shares Outstanding (Diluted Average) for Anaptysbio (ANAB) over the last 6 years, with Dec 2024 value amounting to $28.4 million.

  • Anaptysbio's Shares Outstanding (Diluted Average) rose 0.66% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year increase of 0.66%. This contributed to the annual value of $28.4 million for FY2024, which is 5.42% up from last year.
  • Per Anaptysbio's latest filing, its Shares Outstanding (Diluted Average) stood at $28.4 million for FY2024, which was up 5.42% from $26.9 million recorded in FY2023.
  • Anaptysbio's Shares Outstanding (Diluted Average)'s 5-year high stood at $28.4 million during FY2024, with a 5-year trough of $26.9 million in FY2023.
  • In the last 3 years, Anaptysbio's Shares Outstanding (Diluted Average) had a median value of $28.2 million in 2022 and averaged $27.8 million.
  • As far as peak fluctuations go, Anaptysbio's Shares Outstanding (Diluted Average) declined by 4.41% in 2023, and later increased by 5.42% in 2024.
  • Anaptysbio's Shares Outstanding (Diluted Average) (Yearly) stood at $27.3 million in 2020, then climbed by 0.47% to $27.4 million in 2021, then grew by 2.68% to $28.2 million in 2022, then dropped by 4.41% to $26.9 million in 2023, then rose by 5.42% to $28.4 million in 2024.